Douglas MacFadden

1.6k total citations · 1 hit paper
16 papers, 1.1k citations indexed

About

Douglas MacFadden is a scholar working on Epidemiology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Douglas MacFadden has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 7 papers in Infectious Diseases and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Douglas MacFadden's work include HIV/AIDS Research and Interventions (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers) and HIV Research and Treatment (3 papers). Douglas MacFadden is often cited by papers focused on HIV/AIDS Research and Interventions (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers) and HIV Research and Treatment (3 papers). Douglas MacFadden collaborates with scholars based in Canada and United States. Douglas MacFadden's co-authors include Susanne Churchill, Andrew McMurry, Griffin M. Weber, Isaac S. Kohane, Shawn N. Murphy, Jonathan Bickel, Nich Wattanasin, Sarah Spence, Louis M. Kunkel and Leonard Rappaport and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Douglas MacFadden

16 papers receiving 1.1k citations

Hit Papers

The Co-Morbidity Burden of Children and Young Adults with... 2012 2026 2016 2021 2012 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Douglas MacFadden Canada 12 297 270 203 190 169 16 1.1k
Alexander W. Charney United States 21 72 0.2× 143 0.5× 243 1.2× 653 3.4× 115 0.7× 68 2.0k
Anita L. Weber United States 18 163 0.5× 172 0.6× 87 0.4× 233 1.2× 46 0.3× 37 1.7k
Andrew McMurry United States 8 296 1.0× 93 0.3× 236 1.2× 11 0.1× 166 1.0× 19 902
Jonathan Bickel United States 9 291 1.0× 73 0.3× 127 0.6× 17 0.1× 175 1.0× 17 698
Robert Jakob Switzerland 14 36 0.1× 217 0.8× 168 0.8× 74 0.4× 59 0.3× 33 1.1k
Franck Le Duff France 21 62 0.2× 1.1k 4.0× 304 1.5× 518 2.7× 168 1.0× 63 2.2k
Benjamin Rader United States 19 159 0.5× 214 0.8× 49 0.2× 297 1.6× 121 0.7× 42 1.4k
Nicholas Aderinto Nigeria 15 73 0.2× 118 0.4× 114 0.6× 104 0.5× 63 0.4× 191 942
Danielle Belgrave United Kingdom 29 100 0.3× 122 0.5× 119 0.6× 17 0.1× 69 0.4× 50 2.7k
Philip AbdelMalik Canada 12 49 0.2× 239 0.9× 219 1.1× 47 0.2× 59 0.3× 19 613

Countries citing papers authored by Douglas MacFadden

Since Specialization
Citations

This map shows the geographic impact of Douglas MacFadden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas MacFadden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas MacFadden more than expected).

Fields of papers citing papers by Douglas MacFadden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas MacFadden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas MacFadden. The network helps show where Douglas MacFadden may publish in the future.

Co-authorship network of co-authors of Douglas MacFadden

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas MacFadden. A scholar is included among the top collaborators of Douglas MacFadden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas MacFadden. Douglas MacFadden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
MacFadden, Douglas, et al.. (2019). The SMART IRB platform: A national resource for IRB review for multisite studies. SHILAP Revista de lepidopterología. 3(4). 129–139. 23 indexed citations
2.
Visweswaran, Shyam, Michael J. Becich, Douglas MacFadden, et al.. (2018). Accrual to Clinical Trials (ACT): A Clinical and Translational Science Award Consortium Network. JAMIA Open. 1(2). 147–152. 62 indexed citations
3.
Klann, Jeffrey G., Marc D. Natter, Douglas MacFadden, et al.. (2015). The Scalable Collaborative Infrastructure for a Learning Health System.. AMIA. 1 indexed citations
4.
McMurry, Andrew, Shawn N. Murphy, Douglas MacFadden, et al.. (2013). SHRINE: Enabling Nationally Scalable Multi-Site Disease Studies. PLoS ONE. 8(3). e55811–e55811. 93 indexed citations
5.
Kohane, Isaac S., Andrew McMurry, Griffin M. Weber, et al.. (2012). The Co-Morbidity Burden of Children and Young Adults with Autism Spectrum Disorders. PLoS ONE. 7(4). e33224–e33224. 397 indexed citations breakdown →
6.
Weber, Griffin M., Sue Murphy, Andrew McMurry, et al.. (2009). The Shared Health Research Information Network (SHRINE): A Prototype Federated Query Tool for Clinical Data Repositories. Journal of the American Medical Informatics Association. 16(5). 624–630. 214 indexed citations
7.
Farewell, Vernon T., R. A. Coates, Mary M. Fanning, et al.. (1992). The Probability of Progression to AIDS in a Cohort of Male Sexual Contacts of Men with HIV Disease. International Journal of Epidemiology. 21(1). 131–135. 7 indexed citations
8.
Coates, R. A., Vernon T. Farewell, Janet Raboud, et al.. (1992). Using serial observations to identify predictors of progression to aids in the Toronto Sexual Contact Study. Journal of Clinical Epidemiology. 45(3). 245–253. 29 indexed citations
9.
Reynolds, W. J., et al.. (1991). Allopurinol Sensitivity in a Patient With Chronic Tophaceous Gout: Success of Intravenous Desensitization After Failure of Oral Desensitization. Arthritis & Rheumatism. 34(10). 1329–1331. 16 indexed citations
10.
Major, C, Stanley Read, R. A. Coates, et al.. (1991). Comparison of Saliva and Blood for Human Immunodeficiency Virus Prevalence Testing. The Journal of Infectious Diseases. 163(4). 699–702. 93 indexed citations
11.
Montaner, Julio, Lindsay Lawson, André Gervais, et al.. (1991). Aerosol Pentamidine for Secondary Prophylaxis of AIDS-related Pneumocystis carinii Pneumonia. Annals of Internal Medicine. 114(11). 948–953. 66 indexed citations
12.
Read, Stanley, C Major, R. A. Coates, et al.. (1991). Comparison of three HIV antigen detection kits in sequential sera from a cohort of homosexual men.. PubMed. 4(7). 717–23. 1 indexed citations
13.
Coates, R. A., Vernon T. Farewell, Janet Raboud, et al.. (1990). COFACTORS OF PROGRESSION TO ACQUIRED IMMUNODEFICIENCY SYNDROME IN A COHORT OF MALE SEXUAL CONTACTS OF MEN WITH HUMAN IMMUNODEFICIENCY VIRUS DISEASE. American Journal of Epidemiology. 132(4). 717–722. 55 indexed citations
14.
MacFadden, Douglas, et al.. (1989). Treatment of acute Pneumocystis carinii pneumonia with corticosteroids in a patient with acquired immunodeficiency syndrome. Critical Care Medicine. 17(1). 104–107. 1 indexed citations
15.
MacFadden, Douglas, et al.. (1987). CORTICOSTEROIDS AS ADJUNCTIVE THERAPY IN TREATMENT OF PNEUMOCYSTIS CARINII PNEUMONIA IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME. The Lancet. 329(8548). 1477–1479. 74 indexed citations
16.
MacFadden, Douglas, Jeffrey D. Edelson, & Anthony S. Rebuck. (1985). Pneumocystis carinii pneumonia in the acquired immune deficiency syndrome: response to inadvertent steroid therapy.. PubMed. 132(10). 1161–3. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026